Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.
Kymeta Corporation, a satellite parts manufacturer, raises $50m series C with backing from consortium including multi-university venture fund Osage University Partners.
The Shared Learning Collaborative (SLC), backed by $100m from The Gates Foundation, the Carnegie Corporation, and others, rebrands as new startup inBloom.
Stanford University is joined by Oak Investment Partners and New Enterprise Associates backing the driving intelligence company.